Blog
RSS FeedPosted by Michael Wonder on 29 Apr 2016
Productivity Commission draft report on intellectual property arrangements
29 April 2016 - Medicines Australia notes the release of the draft report from the Productivity Commission concerning Australia’s Intellectual Property ...
Posted by Michael Wonder on 29 Apr 2016
PBS and RPBS Section 85 date of processing and date of supply data
29 April 2016 - The PBS and RPBS Section 85 date of processing and date of supply data has now been ...
Posted by Michael Wonder on 28 Apr 2016
Big pharma gaming patents for extra cash: Productivity Commission
29 April 2016 - Global pharmaceutical giants are boosting revenues by unnecessarily extending patents in Australia, which is also slowing access ...
Posted by Michael Wonder on 28 Apr 2016
Anti-cancer drug Ribomustin added to PBS
28 April 2016 - Up to 30,000 Australians living with a slow-growing form of lymphoma could benefit from a new anti-cancer ...
Posted by Michael Wonder on 28 Apr 2016
Agenda for the July 2016 PBAC meeting
28 April 2016 - The agenda for the July 2016 PBAC meeting is now available. ...
Posted by Michael Wonder on 28 Apr 2016
PBAC to consider first submission for a cellular therapy in July
28 April 2016 - The PBAC will consider a major submission from Amgen for talimogene laherparepvec (Imlygic) at its next scheduled ...
Posted by Michael Wonder on 27 Apr 2016
bDMARDs on the PBS – are they all the same?
28 April 2016 - Adalimumab (Humira) has been listed on the Pharmaceutical Benefits Scheme (PBS) since 2004 for use by certain ...
Posted by Michael Wonder on 26 Apr 2016
How can a price be put on my daughter's life?'
27 April 2016 - A Sunshine Coast mother has failed in her attempt to have the Federal Government list on ...
Posted by Michael Wonder on 25 Apr 2016
Summary of submissions and outcomes from the March 2016 PBAC meeting
26 April 2016 - 69 submissions were considered at the March 2016 PBAC meeting. All bar one were prepared and lodged ...
Posted by Michael Wonder on 25 Apr 2016
Melanoma drug Keytruda denied full listing on PBS
26 April 2016 - A much-hyped melanoma drug credited with saving the life of businessman Ron Walker has been denied a ...
Posted by Michael Wonder on 23 Apr 2016
Outcomes from the PBAC March 2016 meeting
22 April 2016 - The outcomes from the March 2016 PBAC meeting are now available. ...
Posted by Michael Wonder on 23 Apr 2016
Breakthrough cystic fibrosis drug rejected by Australian authorities
22 April 2016 - A break-through drug heralded to dramatically reduce the impacts of cystic fibrosis will not be added to ...
Posted by Michael Wonder on 22 Apr 2016
PBAC to conduct post-market reviews of medicines to treat PAH and bDMARDs to treat chronic plaque psoriasis
22 April 2016 - A public submission process for the post-market reviews of medicines to treat patients with pulmonary arterial hypertension ...
Posted by Michael Wonder on 22 Apr 2016
Record of stakeholder meeting - eculizumab (Soliris) for atypical haemolytic uraemic syndrome (February 2016)
22 April 2016 - A clinical advice meeting was held on 12 February 2016 to discuss the place of eculizumab (Soliris) ...
Posted by Michael Wonder on 21 Apr 2016
PBAC Generic Medicines Working Group communique
21 April 2016 - The third meeting of the Generic Medicines Working Group (GMWG) was held in Canberra on 26 February ...